Bristol Volatility

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>BM</div>
BMY -- USA Stock  

Report: 6th of August 2020  

We consider Bristol Myers very steady. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.0503, which signifies that the company had 0.0503% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Bristol Myers Squibb, which you can use to evaluate future volatility of the firm. Please confirm Bristol Myers Squibb mean deviation of 1.13, downside deviation of 1.53, and risk adjusted performance of 0.138 to double-check if the risk estimate we provide is consistent with the expected return of 0.0726%.

Search Volatility

 
Refresh
Bristol Myers Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Bristol daily returns, and it is calculated using variance and standard deviation. We also use Bristol's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Bristol Myers volatility.

90 Days Market Risk

Very steady

Chance of Distress

Below Average

90 Days Economic Sensitivity

Slowly supersedes the market

Bristol Myers Market Sensitivity And Downside Risk

Bristol Myers Squibb beta coefficient measures the volatility of Bristol stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Bristol stock's returns against your selected market. In other words, Bristol Myers's beta of 0.42 provides an investor with an approximation of how much risk Bristol Myers stock can potentially add to one of your existing portfolios. Let's try to break down what Bristol's beta means in this case. As returns on the market increase, Bristol Myers returns are expected to increase less than the market. However, during the bear market, the loss on holding Bristol Myers will be expected to be smaller as well.
3 Months Beta |Analyze Bristol Myers Squibb Demand Trend
Check current 30 days Bristol Myers correlation with market (DOW)
β

Current Bristol Myers Beta Coefficient

 = 

Bristol Myers Central Daily Price Deviations

It is essential to understand the difference between upside risk (as represented by Bristol Myers's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Bristol Myers stock's daily returns or price. Since the actual investment returns on holding a position in Bristol Myers stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Bristol Myers.

Bristol Myers Squibb Volatility Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Bristol Myers Squibb Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Bristol Myers Projected Return Density Against Market

Considering the 30-days investment horizon, Bristol Myers has a beta of 0.4242 suggesting as returns on the market go up, Bristol Myers average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bristol Myers Squibb will be expected to be much smaller as well. Additionally, Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bristol Myers or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bristol Myers stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bristol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. The company has a negative alpha, implying that the risk taken by holding this equity is not justified. Bristol Myers Squibb is significantly underperforming DOW.
 Predicted Return Density 
      Returns 

Bristol Myers Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bristol Myers or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bristol Myers stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bristol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Considering the 30-days investment horizon, the coefficient of variation of Bristol Myers is 1986.39. The daily returns are destributed with a variance of 2.08 and standard deviation of 1.44. The mean deviation of Bristol Myers Squibb is currently at 1.06. For similar time horizon, the selected benchmark (DOW) has volatility of 2.14
α
Alpha over DOW
=-0.02
β
Beta against DOW=0.42
σ
Overall volatility
=1.44
Ir
Information ratio =-0.11

Bristol Myers Return Volatility

Bristol Myers historical daily return volatility represents how much Bristol Myers stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company has volatility of 1.4421% on return distribution over 30 days investment horizon. By contrast, DOW inherits 1.8606% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

About Bristol Myers Volatility

Volatility is a rate at which the price of Bristol Myers or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Bristol Myers may increase or decrease. In other words, similar to Bristol's beta indicator, it measures the risk of Bristol Myers and helps estimate the fluctuations that may happen in a short period of time. So if prices of Bristol Myers fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.
Last ReportedProjected for 2020
Market Capitalization104.6 B102.2 B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug ManufacturersGeneral classification in the United States and is traded on BATS Exchange. It employs 30000 people.

Bristol Myers Investment Opportunity

DOW has a standard deviation of returns of 1.86 and is 1.29 times more volatile than Bristol Myers Squibb. 12  of all equities and portfolios are less risky than Bristol Myers. Compared to the overall equity markets, volatility of historical daily returns of Bristol Myers Squibb is lower than 12 () of all global equities and portfolios over the last 30 days. Use Bristol Myers Squibb to protect your portfolios against small markets fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Bristol Myers to be traded at $58.55 in 30 days. . Let's try to break down what Bristol's beta means in this case. As returns on the market increase, Bristol Myers returns are expected to increase less than the market. However, during the bear market, the loss on holding Bristol Myers will be expected to be smaller as well.

Bristol Myers correlation with market

correlation synergy
Poor diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb Company and equity matching DJI index in the same portfolio.

Bristol Myers Additional Risk Indicators

The analysis of various secondary risk indicators of Bristol Myers is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Bristol Myers investment, and either accepting that risk or mitigating it. Along with some common measures of Bristol Myers stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging your existing portfolio. Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing the like to determine which investment holds the most risk.
Risk Adjusted Performance0.138
Market Risk Adjusted Performance0.225
Mean Deviation1.13
Semi Deviation1.4
Downside Deviation1.53
Coefficient Of Variation1504.26
Standard Deviation1.52

Bristol Myers Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
National Savings vs. Bristol Myers
Ameri Holdings vs. Bristol Myers
Ford vs. Bristol Myers
Microsoft vs. Bristol Myers
Facebook vs. Bristol Myers
Exxon vs. Bristol Myers
Dun Bradstreet vs. Bristol Myers
GM vs. Bristol Myers
Sprint vs. Bristol Myers
Whiting Petroleum vs. Bristol Myers
Zendesk vs. Bristol Myers
Continue to Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page